Cambridge Major Laboratories and AAIPharma Appoint CEO of Merged Company

November 1, 2013

Cambridge Major Laboratories and AAIPharma Services appoints Patrick D. Walsh as CEO of merged company.

Cambridge Major Laboratories, a provider of pharmaceutical API development and manufacturing, and the CDMO/CMO AAIPharma Services have appointed Patrick D. Walsh as the CEO of the merged company. In October 2013, Cambridge and AAIPharma announced their intent to merge. The combined company forms a supplier of integrated chemistry manufacturing and control (CMC) services, including process chemistry, solid state chemistry, API manufacturing, formulation development, analytical development and testing services, clinical and commercial finished dosage-form manufacturing (oral solid and sterile), and packaging and stability services.

Source: AAIPharma Service